Magnera Corp.: Q4 FY2026 earnings call
What management said about Q4 FY2026, from the documents filed with the SEC on 20 November 2026: press release. Guidance figures: 4 new. The quarter’s numbers.
Key takeaways
- Quarter operating loss included impairment: Quarter net sales were $851 million against $839 million, up 1%. The operating loss of $90 million includes $106 million of goodwill and other impairment. Source
- Adjusted EBITDA rose 8% in quarter: Adjusted EBITDA was $97 million against $90 million, up 8% reported and comparable. Fiscal-year Adjusted EBITDA was $378 million, up 7% reported and 4% comparable. Source
- Americas and Rest of World EBITDA rose: Americas comparable Adjusted EBITDA was $65 million against $61 million, up 7%. Rest of World was $32 million against $29 million, up 10%. Source
- Price-cost spread drove EBITDA increase: Favorable price-cost spread of $9 million was the main driver of the Adjusted EBITDA increase. Source
- Organic volume declined in quarter: Organic volume declined in the quarter. Management primarily attributed this to softer healthcare demand in Americas and general softness in Europe. Source
- Quarter cash from operations and repayments: Quarter cash from operations was $99 million and debt repayments were $57 million. The release labels the cash flow a record. Source
- Fiscal-year free cash flow of $115 million: Fiscal-year free cash flow was $115 million: $178 million of operating cash flow less $63 million of net property, plant and equipment additions. Source
“Our teams delivered these results while navigating inflationary pressures and dynamic demand conditions across our end markets, demonstrating the resilience and flexibility of our operating model.”
Curt Begle, Magnera's CEO
Guidance
| Area | Period | Figure | Against last quarter |
|---|---|---|---|
| Adjusted EBITDA Source | Fiscal 2027 | $390 - $410 million | New |
| Free cash flow Source | Fiscal 2027 | $110 - $130 million | New |
| Cash flow from operations Source | Fiscal 2027 | $195 - $215 million | New |
| Additions to property, plant and equipment, net Source | Fiscal 2027 | (85); % vs. prior year ~6% | New |
What changed from last quarter
- New guidance: Fiscal 2027 guidance for Adjusted EBITDA, free cash flow and cash flow from operations appears for the first time in this release. Source
Fourth-quarter and fiscal-year results
- Quarter operating loss included impairment: Quarter net sales were $851 million against $839 million, up 1%. The operating loss of $90 million includes $106 million of goodwill and other impairment. Source
- Adjusted EBITDA rose 8% in quarter: Adjusted EBITDA was $97 million against $90 million, up 8% reported and comparable. Fiscal-year Adjusted EBITDA was $378 million, up 7% reported and 4% comparable. Source
- Fiscal-year net sales up 3%: Fiscal-year net sales were $3,296 million against $3,204 million, up 3% reported and down 4% comparable. Source
- Net loss larger than last year: Net loss was $141 million in the quarter against $40 million, and $213 million for the fiscal year against $159 million. Source
- Income tax expense rose in quarter: Income tax expense was $34 million in the quarter against $7 million, and $42 million for the fiscal year against a $7 million benefit. Source
Segments and regions
- Americas and Rest of World EBITDA rose: Americas comparable Adjusted EBITDA was $65 million against $61 million, up 7%. Rest of World was $32 million against $29 million, up 10%. Source
- Segment comparable net sales: Americas net sales were $483 million against $473 million comparable. Rest of World net sales were $368 million against $366 million comparable. Source
- Impairment split across segments: Goodwill and other impairment was $65 million in Americas and $41 million in Rest of World. Americas posted an operating loss of $39 million and Rest of World $51 million. Source
- Fiscal-year regional adjusted EBITDA: Fiscal-year comparable Adjusted EBITDA was $251 million in Americas, up 2%, and $127 million in Rest of World, up 8%. Source
“As we enter fiscal 2027, we remain focused on driving profitable growth and advancing our productivity and cost initiatives.”
Curt Begle, Magnera's CEO
Pricing, costs and margins
- Selling prices rose on raw material pass-through: Selling prices rose $43 million, mainly from passing through higher raw material costs. Americas selling prices rose $19 million and Rest of World $24 million. Source
- Price-cost spread drove EBITDA increase: Favorable price-cost spread of $9 million was the main driver of the Adjusted EBITDA increase. Source
- Americas gain from Project CORE: In Americas, a $4 million favorable price-cost spread was tied by management to realized Project CORE benefits and merger synergies. Source
- Rest of World gain partly offset by volume: In Rest of World, a $5 million favorable price-cost spread from Project CORE and synergies was partly offset by lower volumes. Source
- Cost of goods sold and SG&A: Cost of goods sold was $750 million against $751 million. Selling, general and administrative expense was $47 million against $49 million. Source
Demand and volumes
- Organic volume declined in quarter: Organic volume declined in the quarter. Management primarily attributed this to softer healthcare demand in Americas and general softness in Europe. Source
- Rest of World sales flat: Rest of World net sales were essentially flat, as higher selling prices from raw material pass-through offset lower organic volume. Source
- Prior quarter volume had risen: The prior quarter reported volume growth, which the company attributed to consumer solutions strength and North America recovery from winter storms.
“While we remain mindful of the broader macroeconomic environment, we are confident that the strength of our team, our market positions, and our disciplined execution will continue to support sustainable earnings growth and strong cash generation.”
Curt Begle, Magnera's CEO
Cash flow and balance sheet
- Quarter cash from operations and repayments: Quarter cash from operations was $99 million and debt repayments were $57 million. The release labels the cash flow a record. Source
- Fiscal-year free cash flow of $115 million: Fiscal-year free cash flow was $115 million: $178 million of operating cash flow less $63 million of net property, plant and equipment additions. Source
- Debt repayments and total debt fell: Fiscal-year repayments of long-term borrowings were $122 million against $484 million a year earlier. Current and long-term debt was $1,848 million against $1,952 million. Source
- Equity fell and inventories rose: Stockholders' equity was $886 million against $1,064 million. Inventories were $499 million against $474 million. Source
Fiscal 2027 guidance basis
- Forward adjusted EBITDA not reconciled: The release gives no reconciliation of forward-looking Adjusted EBITDA or adjusted free cash flow, citing variability, complexity and low visibility in certain items. Source
- Guidance assumes constant currency: The guidance table footnote states that the fiscal 2027 guidance assumes a constant-currency basis. Source
- Fiscal 2027 midpoint against 2026 actual: The guidance table shows a fiscal 2027 Adjusted EBITDA midpoint of $400 million against the fiscal 2026 actual of $378 million. Source
Cost programs and synergies
- Pro forma Adjusted EBITDA of $397 million: The fiscal-year pro forma bridge adds $21 million of synergies and cost reductions to reach pro forma Adjusted EBITDA of $397 million. Source
- Prior bridge showed $35 million synergies: The prior release's trailing twelve-month bridge showed $35 million of synergies and cost reductions and $405 million of pro forma Adjusted EBITDA. The periods differ.
- Prior quarter Rest of World cost benefits: In the prior quarter, Rest of World Adjusted EBITDA fell as Project CORE and synergy benefits were offset by inflation, pass-through timing and SG&A.
Coming up, as management said on 20 November 2026
- Debt paydown planned in near term: Management said it is committed to strengthening credit metrics by paying down debt in the near term. No amount or timing is given. Source
Figures management reported
Risks management discussed
- Financial: Items excluded from forward non-GAAP figures, such as debt refinancing activity, are described as uncertain and potentially material to GAAP results. Source
Earlier plans management reported on
- Met: Management described Project CORE as successfully implemented, with synergies being realized. Source
Other quarters
Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.